Inventor
Nassim Usman
Inventor
Boulder, CO, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes29%
A61KPreparations for medical, dental or toiletry purposes18%
C07HSugars15%
C07KPeptides11%
C12YEnzymes9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
Y02PClimate change mitigation technologies in the production or processing of goods5%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
8,846,894'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20147,074,601'Nucleozymes'20067,041,817'Synthesis, deprotection, analysis and purification of RNA and ribozymes'20066,849,726'Non-nucleotide containing RNA'20056,713,456'Nucleozymes'20046,649,751'Synthesis, deprotection, analysis and purification of RNA and ribozymes'20036,586,238'Enzymatic nucleic acids containing 5-and or 3-cap structures'20036,555,668'Non-nucleotide containing enzymatic nucleic acid'20036,528,639'Base-modified enzymatic nucleic acid'20036,469,158'Synthesis, deprotection, analysis and purification of RNA and ribozymes'20026,437,117'Synthesis, deprotection, analysis and purification for RNA and ribozymes'20026,365,374'2-deoxy-2-alkylnucleotide containing nucleic acid'20026,362,323'Non-nucleotide containing nucleic acid'20026,353,098'Synthesis, deprotection, analysis and purification of RNA and ribozymes'20026,159,714'Catalytic DNA'20006,140,491'Nucleozymes'20006,117,657'Non-nucleotide containing enzymatic nucleic acid'20005,998,203'Enzymatic nucleic acids containing 5\'-and/or 3\'-cap structures'19995,985,621'2\'-deoxy-2\'-alkylnucleotide containing nucleic acid'19995,891,684'Base-modified enzymatic nucleic acid'19995,891,683'Non-nucleotide containing enzymatic nucleic acid'19995,879,938'Base-modified enzymatic nucleic acid'19995,861,288'Catalytic DNA'19995,831,071'Synthesis deprotection analysis and purification of RNA and ribozymes'19985,804,683'Deprotection of RNA with alkylamine'19985,767,263'Base-modified enzymatic nucleic acid'19985,728,818'Chemical linkage of ribozyme protions'19985,672,501'Base-modified enzymatic nucleic acid'19975,652,094'Nucleozymes'19975,639,647'2\'-deoxy-2\'alkylnucleotide containing nucleic acid'19975,631,360'N-phthaloyl-protected 2\'-amino-nucleoside phosphoramdites'19975,627,053'2\'deoxy-2\'-alkylnucleotide containing nucleic acid'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2003Patents assigned to RIBOZYME PHARM INC (25)· patent assignee history
1997–2004Patents assigned to UNIV MONTREAL (4)· patent assignee history
1997–2006Patents assigned to MASSACHUSETTS INST TECHNOLOGY (3)· patent assignee history
1997–2006Based in Boulder, CO, US· patent location history
1997–2006Based in Boston, MA, US· patent location history
1998–2014Based in Lafayette, CO, US· patent location history
1999–2000Patents assigned to UAB RESEARCH FOUNDATION (2)· patent assignee history
2003–2014Patents assigned to SIRNA THERAPEUTICS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIBOZYME PHARM INC | 25 | 1997–2003 |
| SIRNA THERAPEUTICS INC | 4 | 2003–2014 |
| UNIV MONTREAL | 4 | 1997–2004 |
| MASSACHUSETTS INST TECHNOLOGY | 3 | 1997–2006 |
| UAB RESEARCH FOUNDATION | 2 | 1999–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boulder, CO, US | 25 | 1997–2006 |
| Boston, Massachusetts, US | 4 | 1997–2006 |
| Lafayette, CO, US | 3 | 1998–2014 |